Clinical Trials Logo

Levodopa clinical trials

View clinical trials related to Levodopa.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06275633 Completed - Depression Clinical Trials

Behavioural Profiling of Disease-related Cognitive and Motor Impairment in PD

Start date: March 19, 2019
Phase: N/A
Study type: Interventional

In this project, patients with Parkinson's Disease (PD) will be characterized by measuring cognitive and motor function and relation to effect of Levodopa. Participants will be patients with Parkinson's Disease and healthy controls. It will be investigated if there is a difference between patients with a good measured Levodopa response and with a poor measured response.

NCT ID: NCT02005029 Completed - Parkinson's Disease Clinical Trials

Erythromycin in Parkinson's Disease

Start date: April 2013
Phase: N/A
Study type: Interventional

Gastroparesis (slow stomach emptying) is a common feature of Parkinson's Disease. Levodopa (Sinemet), a common medication for Parkinson's Disease, can make gastroparesis worse. Gastroparesis effects how the levodopa is absorbed and used by the body. This study will explore the possibility of using Erythromycin, a drug commonly used (off label) for gastroparesis, along with levodopa to determine if there is improved levodopa absorption and motor function.

NCT ID: NCT01173731 Completed - Parkinson Disease Clinical Trials

Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Start date: October 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to generate long-term safety, tolerability and efficacy data for AFQ056 in patients who have participated in and completed any AFQ056 phase II study in PD-LID (Parkinson's disease, L-dopa induced dyskinesias).